CCDC14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.219600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.445000E-01
Normal-vs-Stage2
9.104100E-02
Normal-vs-Stage3
1.425980E-01
Normal-vs-Stage4
3.055200E-01
Stage1-vs-Stage2
7.641600E-01
Stage1-vs-Stage3
2.405000E-01
Stage1-vs-Stage4
9.079200E-01
Stage2-vs-Stage3
2.624800E-01
Stage2-vs-Stage4
8.954600E-01
Stage3-vs-Stage4
3.552200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.785700E-02
Normal-vs-AfricanAmerican
5.886400E-01
Normal-vs-Asian
3.649600E-01
Caucasian-vs-AfricanAmerican
8.109200E-01
Caucasian-vs-Asian
1.506370E-01
AfricanAmerican-vs-Asian
8.636400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.379600E-02
Normal-vs-Female
1.463220E-01
Male-vs-Female
5.885200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.051200E-01
Normal-vs-Age(41-60Yrs)
4.308200E-02
Normal-vs-Age(61-80Yrs)
1.057230E-01
Normal-vs-Age(81-100Yrs)
1.008610E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.479600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.100000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.900600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.905000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.837200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.945800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.080230E-01
Normal-vs-Daily Drinker
2.045600E-01
Normal-vs-Weekly Drinker
1.924970E-01
Normal-vs-Occasional Drinker
2.104200E-02
Normal-vs-Social Drinker
4.687800E-01
Non Drinker-vs-Daily Drinker
9.155000E-01
Non Drinker-vs-Weekly Drinker
8.308400E-01
Non Drinker-vs-Occasional Drinker
3.509400E-01
Non Drinker-vs-Social Drinker
2.891800E-01
Daily Drinker-vs-Weekly Drinker
8.027200E-01
Daily Drinker-vs-Occasional Drinker
5.077400E-01
Daily Drinker-vs-Social Drinker
3.541000E-01
Weekly Drinker-vs-Occasional Drinker
3.052400E-01
Weekly Drinker-vs-Social Drinker
4.936400E-01
Occasional Drinker-vs-Social Drinker
1.175190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.695830E-01
Normal-vs-Grade 2
4.691800E-02
Normal-vs-Grade 3
7.010200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.224500E-02
Grade 1-vs-Grade 3
4.818300E-02
Grade 1-vs-Grade 4
1.695830E-01
Grade 2-vs-Grade 3
6.765000E-01
Grade 2-vs-Grade 4
4.691800E-02
Grade 3-vs-Grade 4
7.010200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.530500E-02
Normal-vs-NonDiabetic
1.370190E-01
Diabetic-vs-NonDiabetic
5.765500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.744200E-01
Normal-vs-NoPancreatitis
4.483500E-02
Pancreatitis-vs-NoPancreatitis
1.319810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.045900E-02
Normal-vs-N1
9.266400E-02
N0-vs-N1
6.459600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.660800E-01
Normal-vs-TP53-NonMutant
1.606000E-01
TP53-Mutant-vs-TP53-NonMutant
3.062600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
